share_log

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga Real-time News ·  Jan 4, 2023 08:08

Gainers

  • Geron (NASDAQ:GERN) shares increased by 57.1% to $3.77 during Wednesday's pre-market session. The company's market cap stands at $1.4 billion.
  • Tenax Therapeutics (NASDAQ:TENX) stock increased by 55.46% to $0.17. The market value of their outstanding shares is at $7.6 million.
  • Lannett (NYSE:LCI) stock moved upwards by 22.08% to $0.65. The market value of their outstanding shares is at $27.2 million.
  • Applied Therapeutics (NASDAQ:APLT) shares rose 21.85% to $0.92. The market value of their outstanding shares is at $44.0 million.
  • Nymox Pharmaceutical (NASDAQ:NYMX) stock increased by 20.27% to $0.42. The market value of their outstanding shares is at $38.0 million.
  • Jasper Therapeutics (NASDAQ:JSPR) stock increased by 18.97% to $3.26. The market value of their outstanding shares is at $120.8 million.

Losers

  • Vera Therapeutics (NASDAQ:VERA) stock declined by 60.8% to $7.17 during Wednesday's pre-market session. The company's market cap stands at $198.3 million.
  • Lucira Health (NASDAQ:LHDX) shares decreased by 31.72% to $0.41. The market value of their outstanding shares is at $16.6 million.
  • Reshape Lifesciences (NASDAQ:RSLS) shares decreased by 27.78% to $11.31. The market value of their outstanding shares is at $5.4 million.
  • Phathom Pharmaceuticals (NASDAQ:PHAT) shares declined by 21.69% to $9.39. The market value of their outstanding shares is at $390.8 million.
  • Gelesis Holdings (NYSE:GLS) stock fell 17.25% to $0.43. The market value of their outstanding shares is at $31.4 million.
  • Cingulate (NASDAQ:CING) stock declined by 16.61% to $0.85. The company's market cap stands at $9.6 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment